Mauricio D Dorfman

Dr. Mauricio D Dorfman

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JBJineta Banerjee
Jineta Banerjee
MDMauricio D Dorfman
Mauricio D Dorfman
RFRachael Fasnacht
Rachael Fasnacht
JDJohn D. Douglass
John D. Douglass
AWAlice C. Wyse-Jackson
Alice C. Wyse-Jackson
JTJoshua P Thaler
Joshua P Thaler
Both hypothalamic microglial inflammation and melanocortin pathway dysfunction contribute to diet-induced obesity (DIO) pathogenesis. Previous studies involving models of altered microglial signaling demonstrate altered DIO susceptibility with corresponding POMC neuron cytological changes, suggesting a link between microglia and the melanocortin system. We addressed this hypothesis using the specific microglial silencing molecule, CX3CL1 (fractalkine), to determine whether reducing hypothalamic microglial activation can restore POMC/melanocortin signaling to protect against DIO. We performed metabolic analyses in high fat diet (HFD)-fed mice with targeted viral overexpression of CX3CL1 in the hypothalamus. Electrophysiologic recording in hypothalamic slices from POMC-MAPT-GFP mice was used to determine the effects of HFD feeding and microglial silencing via minocycline or CX3CL1 on GFP-labeled POMC neurons. Finally, mice with hypothalamic overexpression of CX3CL1 received central treatment with the melanocortin receptor antagonist SHU9119 to determine whether melanocortin signaling is required for the metabolic benefits of CX3CL1. Hypothalamic overexpression of CX3CL1 increased leptin sensitivity and POMC gene expression, while reducing weight gain in animals fed an HFD. In electrophysiological recordings from hypothalamic slice preparations, HFD feeding was associated with reduced POMC neuron excitability and increased amplitude of inhibitory postsynaptic currents. Microglial silencing using minocycline or CX3CL1 treatment reversed these HFD-induced changes in POMC neuron electrophysiologic properties. Correspondingly, blockade of melanocortin receptor signaling in vivo prevented both the acute and chronic reduction in food intake and body weight mediated by CX3CL1. Our results show that suppressing microglial activation during HFD feeding reduces DIO susceptibility via a mechanism involving increased POMC neuron excitability and melanocortin signaling.

2 July 2026 in Metabolism
Verified
Journal Article
Closed access
IVInmaculada Velasco
Inmaculada Velasco
JFJeremy M. Frey
Jeremy M. Frey
VBVladislav Baglaev
Vladislav Baglaev
TJTristan Jafari
Tristan Jafari
THThomas Huang
Thomas Huang
MDMauricio D Dorfman
Mauricio D Dorfman

1 May 2023 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
MDMauricio D Dorfman
Mauricio D Dorfman
TMThomas Monfeuga
Thomas Monfeuga
SMSusan J. Melhorn
Susan J. Melhorn
JKJenny E. Kanter
Jenny E. Kanter
JFJeremy M. Frey
Jeremy M. Frey
JTJoshua P. Thaler
Joshua P. Thaler
This study provides evidence that hypothalamic gliosis is a key early event through which androgen deficiency in combination with a Western-style diet might lead to cardiometabolic dysregulation in males. Furthermore, this work provides the first evidence in humans of a positive association between hypothalamic gliosis and LDL-cholesterol, advancing our knowledge of CNS influences on CVD risk progression.

1 September 2025 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
CACamila Astudillo-Guerrero
Camila Astudillo-Guerrero
DFDaniela Fernandois
Daniela Fernandois
ECEmilie Caron
Emilie Caron
VPVincent Prévot
Vincent Prévot
JTJoshua P Thaler
Joshua P Thaler
GCGonzalo Cruz
Gonzalo Cruz
This study shows that time-restricted feeding (TRF) improves glucose tolerance in obese mice independently of weight loss. Surprisingly, this benefit is linked to increased hypothalamic gliosis, challenging the view that gliosis is solely detrimental in obesity. Although TRF elevates circulating β-hydroxybutyrate (BHB), peripheral and central BHB delivery fails to mimic TRF’s glycemic benefits or affect hypothalamic gliosis. These findings suggest gliosis may play a previously unrecognized role in mediating TRF’s metabolic benefits.

29 August 2006 in Annual Review of Biomedical Sciences
Verified
Journal Article
Open access
PDF file
MDMauricio D Dorfman
Mauricio D Dorfman
AAAv Araya
Av Araya
JFJf Fiedler
Jf Fiedler
SLSl Luna
Sl Luna
Carmen RomeroCarmen Romero
Carmen Romero
HLHernan E Lara
Hernan E Lara
Role of Stress and Sympathetic Innervation in the Development of Polycystic Ovary Syndrome

15 October 2026 in Molecular Metabolism
Verified
Journal Article
Open access
ACAlexander Carbonell
Alexander Carbonell
JSJarrad M. Scarlett
Jarrad M. Scarlett
EJEllie I. James
Ellie I. James
KFKendra L. Francis
Kendra L. Francis
KTKathryn Tyler
Kathryn Tyler
KAKimberly M. Alonge
Kimberly M. Alonge
The hypothalamic arcuate nucleus (ARC) contains neuronal populations crucial to the regulation of energy and glucose homeostasis. Many of these neurons are enmeshed by specialized extracellular matrix structures known as perineuronal nets (PNNs) that are comprised of chondroitin sulfate proteoglycans, including aggrecan (ACAN), and attached chondroitin sulfate-glycosaminoglycans. In mice, the effect of high-fat diet (HFD) to increase the abundance of ARC PNNs has been implicated in obesity- and diabetes-associated metabolic impairments. However, neither the biochemical nature nor the time course of these HFD-induced PNN changes is known. In this current work, we report that the response of ARC PNNs to HFD feeding is biphasic, characterized by a steady increase in abundance during the first ∼3 months, followed by a gradual decrease at later time points, as diet-induced obesity (DIO) becomes more fully established. Our findings suggest that this novel, biphasic patten of PNN remodeling is 1) driven by weight gain rather than by HFD composition per se, 2) specific to the hypothalamic ARC region, and 3) parallels obesity-associated changes in the circulating glucose level. Furthermore, histochemical analysis reveals that the early increase of ARC PNNs is due primarily to changes in CS glycan attachments rather than the underlying proteoglycan core protein, while long-term HFD associates with reductions of both CS glycans and ACAN. This biphasic remodeling process becomes detectable with the onset of excess weight gain and is paralleled by obesity-associated changes in glycemia. Based on these findings, we conclude that in response to HFD feeding, ARC PNNs exhibit a degree of plasticity not seen in other brain areas and that dynamic PNN remodeling associates with changes in peripheral glycemia.